Clinical Trials Directory

Trials / Completed

CompletedNCT03751930

Intestinal Microbiota, Tryptophan and Autism

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Accepted

Summary

Autism Spectrum Disorder refers to complex neuro-developmental disorders that affect social communication and behavioral adaptation. Currently, the diagnosis of Autism Spectrum Disorder is based on a clinical examination that is performed classically during the first three years of life. The heterogeneity of the disorders occurring in autism make pathologies difficult to diagnose and manage. The overall goal of this project is the identification of metabolic biomarkers based on clinical profile. The best characterization of physiopathological pathways will ultimately allow the identification of subgroups of subjects and facilitate the development of targeted therapeutics. The proposed work aims to test the hypothesis of a disruption of tryptophan metabolism in Autism Spectrum Disorder via the gut microbiota.

Detailed description

Autism Spectrum Disorder refers to complex neuro-developmental disorders that affect social communication and behavioral adaptation. In France, Autism Spectrum Disorderaffects about 1 in 100 people according to international criteria and is diagnosed in early childhood. Currently, the diagnosis of Autism Spectrum Disorder is based on a clinical examination that is performed classically during the first three years of life. The heterogeneity of the disorders occurring in autism make pathologies difficult to diagnose and manage. The overall goal of this project is the identification of metabolic biomarkers based on clinical profile (based on behavioral and cognitive markers). The best characterization of physiopathological pathways (from the molecular scale to the phenotypic scale) will ultimately allow the identification of subgroups of subjects and facilitate the development of targeted therapeutics. The proposed work aims to test the hypothesis of a disruption of tryptophan metabolism in Autism Spectrum Disorder via the gut microbiota.

Conditions

Interventions

TypeNameDescription
OTHERSamplesUrinary and faecal samples

Timeline

Start date
2019-01-02
Primary completion
2021-10-28
Completion
2021-10-28
First posted
2018-11-23
Last updated
2022-05-25

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03751930. Inclusion in this directory is not an endorsement.